Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells
January 16th, 2026
This experimental protocol provides a stable, cost-effective, and efficient method that combines lncRNA knockdown with colony-forming assays to quantify the effect of lncRNA on osteosarcoma cell proliferation.
My research focuses on osteosarcoma and aims to investigate how LncRNA-knockdown influences long-term proliferative capacity using colony information assays. To begin, seed 5 times 10 to the power of 5 143B osteosarcoma cells into two 10 centimeter culture dishes. Culture the cells in complete DMEM supplemented with 10%fetal bovine serum at 37 degrees Celsius in a 5%carbon dioxide incubator.
Prepare the transfection reagents 24 hours later, including plasmids, polyethylenimine, and OptiMinium Essential Medium. Vortex each reagent and allow them to equilibrate to room temperature before use. Now, label four 1.5 milliliter microcentrifuge tubes for plasmids and polyethylenimine using a marker pen.
Pipette 500 microliters of OptiMinium Essential Medium to each tube. Then add 10 micrograms of plasmid to the corresponding plasmid tube and pipette 30 microliters of polyethylenimine into each polyethylenimine tube. Mix each tube gently by pipetting up and down and incubate.
Now combine each plasmid tube with its corresponding polyethylenimine tube. Mix gently and incubate the mixture at room temperature for 20 minutes. Gently aspirate the culture medium from the dishes containing the 143B cells.
Add seven milliliters of serum-free medium to each dish and label the dishes according to the plasmid to be added. Add the prepared transfection mixture dropwise to the corresponding culture dish. Add the mixture slowly in a circular motion from the outer edge toward the center of the dish.
Incubate the cells at 37 degrees Celsius in a 5%carbon dioxide incubator. Discard the supernatant 8 to 12 hours later. Then add 10 milliliters of complete DMEM to the culture dish and incubate.
Observe the cells under a fluorescence microscope 72 hours after replacing the medium, Remove the medium from the culture dishes. Add 1.5 milliliters of trypsin-EDTA acid to digest the cells. Cells gently pipette to detach the cells.
Then add five milliliters of complete medium to terminate digestion. Transfer the cell suspension into a 15 milliliter microcentrifuge tube. Then pipette 20 microliters of the cell suspension into a hemocytometer to count the cells.
Collect 3 times 10 to the power of 5 cells for ribonucleic acid extraction to verify knockdown efficiency. Now seed 2 times 10 to the power of 3 cells per well into a six-well plate. Pipette complete DMEM to a final volume of two milliliters.
Culture the cells at 37 degrees Celsius in a 5%carbon dioxide incubator. Monitor colony formation daily. Terminate the culture when most colonies in the control group contain at least 50 cells or after 10 to 14 days of incubation.
After discarding the supernatant, wash the cells twice with one milliliter of PBS per well, discarding the solution after each wash. Fix the cells in one milliliter of 10%formalin solution for 15 minutes. Discard the fixative, then wash the cells twice with one milliliter per well of PBS.
Stain the cells with one milliliter of 0.5%crystal violet solution for 10 to 30 minutes. Then gently wash the plate with slowly running tap water. Air dry the cells at room temperature.
Capture images of the colonies using a camera. Transfection efficiency of 143B cells was confirmed by fluorescence microscopy 72 hours after transfection, indicating efficient plasmid delivery in both conditions. RT-qPCR reaction analysis showed that SNHG6 expression was significantly reduced in 143B cells transfected with shSNHG6 compared with the shNC group.
Colony formation assays revealed a significant reduction in the number and size of colonies in the SNHG6 knockdown group compared to the control group. This protocol assesses single-cell long-term proliferation, providing higher biological relevance and more definitive outcomes than short-term metabolic-based proliferation assays. Future studies will expand this protocol to additional LncRNAs and tumor models to systematically explore mechanisms regulating cancer cell proliferative potential.
View the full transcript and gain access to thousands of scientific videos
Overview
This experimental protocol outlines a method to investigate the impact of lncRNA knockdown on osteosarcoma cell proliferation through colony-forming assays. The approach is designed to be stable, cost-effective, and efficient.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Cancer Research
Background
- Osteosarcoma is a type of bone cancer that primarily affects adolescents and young adults.
- Long non-coding RNAs (lncRNAs) play a significant role in regulating gene expression and cellular processes.
- Understanding the role of lncRNAs in cancer can provide insights into potential therapeutic targets.
- Colony-forming assays are essential for assessing the long-term proliferative capacity of cancer cells.
Purpose of Study
- To quantify the effect of lncRNA knockdown on the proliferation of osteosarcoma cells.
- To establish a reliable protocol for conducting colony-forming assays in this context.
- To explore the mechanisms regulating cancer cell proliferation through lncRNA interactions.
Methods Used
- Transfection of 143B osteosarcoma cells with lncRNA-targeting plasmids.
- Use of serum-free medium for transfection and subsequent culture in complete DMEM.
- Colony formation assays to monitor cell proliferation over a period of 10 to 14 days.
- Fluorescence microscopy and RT-qPCR to assess transfection efficiency and lncRNA expression levels.
Main Results
- Significant reduction in SNHG6 expression in transfected cells compared to controls.
- Colony formation assays showed decreased number and size of colonies in the lncRNA knockdown group.
- The protocol demonstrated higher biological relevance compared to short-term assays.
- Future studies will extend this approach to other lncRNAs and tumor models.
Conclusions
- This protocol effectively assesses the impact of lncRNA on osteosarcoma cell proliferation.
- It provides a framework for further research into lncRNA functions in cancer biology.
- Results indicate that lncRNA knockdown can significantly affect cancer cell growth and viability.
Frequently Asked Questions
Executive Industry Relevance
Colony formation assays provide a robust platform for evaluating the long-term proliferative capacity of osteosarcoma cells following lncRNA knockdown, directly informing target validation and mechanistic de-risking in oncology discovery pipelines. Quantitative assessment of single-cell proliferation enables high-confidence differentiation between functional and non-functional lncRNA targets, supporting risk-adjusted portfolio decisions. This workflow is broadly applicable for assessing lncRNA-regulated proliferation across diverse tumor models, enhancing translational continuity.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables functional interrogation of lncRNA targets in disease-relevant osteosarcoma models.
- Supports mechanistic de-risking by linking lncRNA knockdown to quantifiable changes in proliferative capacity.
- Facilitates prioritization of lncRNA candidates for further preclinical evaluation.
Screening & Assay Development
- Establishes a reproducible, quantitative assay for long-term cell proliferation.
- Provides standardized outputs for cross-comparison of lncRNA knockdown effects.
- Enables reliable assessment of compound or genetic perturbation impact on colony formation.
Translational & Preclinical Research
- Aligns in vitro proliferation outcomes with disease-relevant tumor biology.
- Supports continuity from discovery-stage target validation to preclinical model selection.
- Informs biomarker development by linking lncRNA expression to functional cellular outcomes.
Pipeline & Workflow Integration
This protocol integrates into the discovery-to-preclinical continuum by providing a validated method for functional target assessment and quantitative readouts of proliferative potential.
- Discovery Biology: Enables hypothesis testing of lncRNA function in osteosarcoma cell proliferation.
- Screening: Delivers standardized, reproducible colony formation data for candidate triage.
- Analytics: Provides quantitative measurements of colony number and size for statistical comparison.
- Translational Research: Bridges in vitro findings to in vivo model selection and biomarker strategies.
- Enterprise Reuse: Offers a scalable assay adaptable to additional lncRNAs and tumor types.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in lncRNA target validation and reduces mechanistic ambiguity.
- Operational Value: Standardizes long-term proliferation assessment with high reproducibility and scalability.
- Strategic Value: Improves go/no-go decisions and capital allocation by providing definitive functional data.
- Portfolio Impact: Enables risk-adjusted prioritization of lncRNA targets for advancement.
Implementation Considerations
- Requires expertise in cell culture, transfection, and quantitative assay analysis.
- Needs access to fluorescence microscopy, RT-qPCR, and colony imaging infrastructure.
- Demands cross-team standardization of assay setup and data interpretation.
- Adaptable to various tumor cell lines and lncRNA targets with protocol optimization.
- Dependent on robust statistical analysis to ensure reproducibility and comparability.
